newsfilter
← Latest News
GlobeNewswire·

Alpha Tau Announces Full Year 2025 Financial Results and Provides Corporate Update

- Tremendous activity in recent months, including receipt of Japanese marketing approval, the fifth parallel U.S. trial approval, data from pancreatic cancer trials presented at ASCO GI Symposium, and the first brain